FDA Clearance Tracker · K243956
TG-980P CO2 Sensor Kit (TG-980P); TG-980P1 CO2 Sensor Kit (TG-980P1)
Last checked: Nov 20, 2026Latest source record: Jun 10, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jun 10, 2025
Substantially Equivalent
Time to decision
169 days
Received Dec 23, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K243956
- Device name
- TG-980P CO2 Sensor Kit (TG-980P); TG-980P1 CO2 Sensor Kit (TG-980P1)
- Applicant
- Nihon Kohden Corporation
- Applicant location
- Tokyo, JP
- Received
- Dec 23, 2024
- Decided
- Jun 10, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 868.1400
- Specialty
- Anesthesiology & Respiratory
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CCK. The earliest in FDA's data is K770123, decided Feb 1, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243956
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Nihon Kohden Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251641 · Decided Aug 12, 2026 · 440 days after receipt
Device type: Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase (CCK) · Anesthesiology & Respiratory
K260747 · Decided May 6, 2026 · 61 days after receipt
Device type: Blood Pressure Cuff (DXQ) · Cardiology
K251366 · Decided Oct 9, 2025 · 161 days after receipt
Device type: Non-Normalizing Quantitative Electroencephalograph Software (OLT) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.